e-learning
resources
Milan 2017
Monday, 11.09.2017
The wide spectrum of ILDs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening
M. Garcia Moyano (Barakaldo, Spain)
Source:
International Congress 2017 – The wide spectrum of ILDs
Session:
The wide spectrum of ILDs
Session type:
Poster Discussion
Number:
2954
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Garcia Moyano (Barakaldo, Spain). Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening. 2954
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Transplantation pulmonaire à l’heure de la médecine de précision Lung transplantation in the era of precision medicine
Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation
Clinical characteristics of anti-Jo-1-positive interstitial lung disease
Related content which might interest you:
Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Morbidity and mortality in patients with chronic obstructive pulmonary disease and cachexia
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2011; 39: 125-132
Year: 2012
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2012; 39: 125-132
Year: 2012
Pulmonary and extrapulmonary morbidity and mortality in COPD
Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course
Year: 2012
Effect of delayed secondary care referral on morbidity and mortality in idiopathic pulmonary fibrosis patients treated with antifibrotics
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
The impact of dynamic lung hyperinflation on morbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Hospital readmission rate and mortality after severe exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
Increase in post-transplant survival and quality of life in pulmonary fibrosis with and without telomere dysfunction
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020
Factors affecting mortality and morbidity in patients with bronchiectasis
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010
Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Hospital readmission increases short and long – term mortality in patients with interstitial lung disease after acute respiratory worsening.
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Cardiovascular mortality and morbidity in pulmonary embolism
Source: Eur Respir Monogr 2020; 88: 184-197
Year: 2020
Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Year: 2021
Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality
Source: Eur Respir J 2010; 35: 1303-1311
Year: 2010
Predictors of death or transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept